LeMaitre Vascular (LMAT) Competitors $97.02 +2.46 (+2.60%) As of 03:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LMAT vs. STVN, IRTC, GKOS, BLCO, TMDX, SLNO, NVST, LIVN, WRBY, and INSPShould you be buying LeMaitre Vascular stock or one of its competitors? The main competitors of LeMaitre Vascular include Stevanato Group (STVN), iRhythm Technologies (IRTC), Glaukos (GKOS), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry. LeMaitre Vascular vs. Its Competitors Stevanato Group iRhythm Technologies Glaukos Bausch + Lomb TransMedics Group Soleno Therapeutics Envista LivaNova Warby Parker Inspire Medical Systems Stevanato Group (NYSE:STVN) and LeMaitre Vascular (NASDAQ:LMAT) are both mid-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment. Which has more risk & volatility, STVN or LMAT? Stevanato Group has a beta of 0.55, meaning that its stock price is 45% less volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Which has stronger valuation & earnings, STVN or LMAT? Stevanato Group has higher revenue and earnings than LeMaitre Vascular. Stevanato Group is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStevanato Group€1.19B5.86€127.45M€0.5442.78LeMaitre Vascular$219.86M9.99$44.04M$2.0647.10 Is STVN or LMAT more profitable? LeMaitre Vascular has a net margin of 20.08% compared to Stevanato Group's net margin of 11.73%. LeMaitre Vascular's return on equity of 13.67% beat Stevanato Group's return on equity.Company Net Margins Return on Equity Return on Assets Stevanato Group11.73% 10.34% 6.21% LeMaitre Vascular 20.08%13.67%9.14% Do insiders & institutionals have more ownership in STVN or LMAT? 84.6% of LeMaitre Vascular shares are owned by institutional investors. 9.5% of LeMaitre Vascular shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts rate STVN or LMAT? LeMaitre Vascular has a consensus price target of $97.60, suggesting a potential upside of 0.60%. Given LeMaitre Vascular's higher probable upside, analysts plainly believe LeMaitre Vascular is more favorable than Stevanato Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.83LeMaitre Vascular 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40 Does the media prefer STVN or LMAT? In the previous week, LeMaitre Vascular had 2 more articles in the media than Stevanato Group. MarketBeat recorded 7 mentions for LeMaitre Vascular and 5 mentions for Stevanato Group. LeMaitre Vascular's average media sentiment score of 1.51 beat Stevanato Group's score of 1.32 indicating that LeMaitre Vascular is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LeMaitre Vascular 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryLeMaitre Vascular beats Stevanato Group on 12 of the 17 factors compared between the two stocks. Get LeMaitre Vascular News Delivered to You Automatically Sign up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LMAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LMAT vs. The Competition Export to ExcelMetricLeMaitre VascularMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.20B$10.77B$5.75B$9.89BDividend Yield0.84%1.84%6.66%4.49%P/E Ratio47.1221.6982.9726.58Price / Sales9.9928.68500.68162.32Price / Cash39.9225.1325.7028.92Price / Book6.063.4110.796.52Net Income$44.04M$211.94M$3.29B$266.21M7 Day Performance1.84%-3.51%-0.07%-0.96%1 Month Performance15.01%7.69%6.98%3.61%1 Year Performance9.63%-8.33%49.86%24.03% LeMaitre Vascular Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LMATLeMaitre Vascular3.2405 of 5 stars$97.02+2.6%$97.60+0.6%+8.1%$2.20B$219.86M47.12490Positive NewsSTVNStevanato GroupN/A€21.99-2.8%N/A+6.6%€6.66B€1.19B40.725,521Positive NewsIRTCiRhythm Technologies1.5862 of 5 stars$165.68-2.0%$162.64-1.8%+159.7%$5.43B$591.84M-56.552,000Positive NewsGKOSGlaukos4.786 of 5 stars$91.78-2.5%$127.42+38.8%-29.0%$5.40B$383.48M-55.62780Positive NewsBLCOBausch + Lomb2.2512 of 5 stars$14.57-2.5%$15.56+6.8%-9.8%$5.29B$4.79B-18.6713,500Positive NewsTMDXTransMedics Group3.8921 of 5 stars$114.97-4.1%$123.00+7.0%-32.9%$4.09B$441.54M59.57210Positive NewsAnalyst ForecastSLNOSoleno Therapeutics4.5656 of 5 stars$66.51-3.0%$115.09+73.0%+41.6%$3.64BN/A-16.0730News CoveragePositive NewsNVSTEnvista3.8008 of 5 stars$21.15-2.6%$20.92-1.1%+13.9%$3.61B$2.51B66.1012,300Positive NewsLIVNLivaNova1.9069 of 5 stars$56.35+0.8%$59.71+6.0%+14.1%$3.05B$1.25B-14.492,900News CoveragePositive NewsAnalyst ForecastWRBYWarby Parker1.8023 of 5 stars$26.18-3.1%$24.06-8.1%+81.6%$2.84B$771.32M-373.883,780News CoveragePositive NewsINSPInspire Medical Systems4.9942 of 5 stars$93.20-2.9%$165.62+77.7%-51.7%$2.84B$802.80M53.881,246Positive NewsAnalyst ForecastInsider Trade Related Companies and Tools Related Companies STVN Alternatives IRTC Alternatives GKOS Alternatives BLCO Alternatives TMDX Alternatives SLNO Alternatives NVST Alternatives LIVN Alternatives WRBY Alternatives INSP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LMAT) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersMusk Warns. Trump Acts. Your Retirement May Depend on ItWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredWall Street Legend Names #1 ‘Hidden’ AI Stock50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LeMaitre Vascular, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LeMaitre Vascular With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LMAT Stock Alerts